Participants 12 114 6
Japanese breast cancer patients treated with pre-operative and post-operative anastrozole or tamoxifen
Participants 177 328 6
subgroup of postmenopausal, estrogen receptor-positive Japanese breast cancer patients from the Pre-Operative "Arimidex" Compared with Tamoxifen trial,
Participants 450 523 4
Patients with large, potentially operable, locally-advanced breast cancer
